Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy.

3D printing Clinical Trial Digital Manufacturing Head and Neck Cancer Intraoral scanning Mucositis Oral stent Patient-reported outcomes Radiation therapy Stereolithography

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
17 Jul 2024
Historique:
received: 28 03 2024
accepted: 09 07 2024
medline: 19 7 2024
pubmed: 19 7 2024
entrez: 18 7 2024
Statut: aheadofprint

Résumé

We describe the development of 3D-printed stents using our digital workflow and their effects on patients enrolled in the lead-in phase of a multi-center, randomized Phase-II trial. Digital dental models were created for patients using intraoral scanning. Digital processes were implemented to develop the mouth-opening, tongue-depressing, and tongue-lateralizing stents using stereolithography. Time spent and material 3D-printing costs were measured. Physicians assessed mucositis using the Oral Mucositis Assessment Scale (OMAS) and collected MD Anderson Symptom Inventory (MDASI) reports and adverse events (AEs) from patients at various time points (TPs). OMAS and MDASI results were evaluated using paired t-test analysis. 18 patients enrolled into the lead-in phase across 6 independent clinical sites in the USA. 15 patients received stents (average design and fabrication time, 8 h; average material 3D-printing cost, 11 USD). 10 eligible patients with complete OMAS and MDASI reports across all TPs were assessed. OMAS increased significantly from baseline to week 3 of treatment (mean difference = 0.34; 95 % CI, 0.09-0.60; p = 0.01). MDASI increased significantly from baseline to week 3 of treatment (mean difference = 1.02; 95 % CI, 0.40-1.70; p = 0.005), and week 3 of treatment to end of treatment (mean difference = 1.90; 95 % CI, 0.90-2.92; p = 0.002). AEs (grades 1-3) were reported by patients across TPs. Mucositis and radiation dermatitis were primarily attributed to chemoradiation. 3D-printed stents were successfully fabricated and well tolerated by patients. As patients enroll in the randomized phase of this trial, data herein will establish a baseline for comparative analysis.

Identifiants

pubmed: 39024700
pii: S1368-8375(24)00262-8
doi: 10.1016/j.oraloncology.2024.106944
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106944

Informations de copyright

Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Rance Tino (R)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Millicent A Roach (MA)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Gabriela D Fuentes (GD)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Anshuman Agrawal (A)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Mohamed Zaid (M)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Dylan J Cooper (DJ)

Department of Otolaryngology, Head and Neck Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11550, USA.

Nimit Bajaj (N)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Ruitao Lin (R)

Department of Biostatistics, Division of VP, Research, The University of Texas MD Anderson Cancer Center, 7007 Bertner Avenue, Houston, TX 77030, USA. Electronic address: rlin@mdanderson.org.

Lianchun Xiao (L)

Department of Biostatistics, Division of VP, Research, The University of Texas MD Anderson Cancer Center, 7007 Bertner Avenue, Houston, TX 77030, USA. Electronic address: lxiao@mdanderson.org.

Lauren L Mayo (LL)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center League City, League City, TX 77573, USA.

Lee R Wiederhold (LR)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center League City, League City, TX 77573, USA.

Shalin J Shah (SJ)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center Sugar Land, Sugar Land, TX 77478, USA.

Molly K Tate (MK)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center West Houston, Houston, TX 77079, USA.

Gregory M Chronowski (GM)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center West Houston, Houston, TX 77079, USA.

Jay P Reddy (JP)

Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center The Woodlands, Conroe, TX 77384, USA.

Megan Mezera (M)

Department of Radiation Oncology, MD Anderson Cancer Center at Cooper, Camden, NJ 08103, USA.

Justin M Mann (JM)

Department of Radiation Oncology, MD Anderson Cancer Center at Cooper, Camden, NJ 08103, USA.

Mark Augspurger (M)

Department of Radiation Oncology, Baptist MD Anderson Cancer Center, Jacksonville, FL 32207, USA.

Adegbenga O Otun (AO)

Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Mark S Chambers (MS)

Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Eugene J Koay (EJ)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Electronic address: EKoay@mdanderson.org.

Classifications MeSH